Safety and Tolerability of Angiotensin Receptor-Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Care Setting: A Subgroup Analysis of the PARADISE-MI Trial

被引：0

作者：

De Pasquale, Carmine G. ^{[1
,2
]}

Claggett, Brian ^{[3
,4
]}

Jering, Karola ^{[3
,4
]}

McMurray, John J. V. ^{[6
]}

Mann, Douglas ^{[7
]}

Miao, Zi Michael ^{[3
,4
]}

Granger, Christopher B. ^{[8
]}

Kober, Lars ^{[9
]}

Maggioni, Aldo P. ^{[10
]}

Rouleau, Jean-Lucien ^{[11
]}

Solomon, Scott D. ^{[3
,4
]}

Steg, Philippe Gabriel ^{[12
]}

van der Meer, Peter ^{[13
]}

Braunwald, Eugene ^{[4
,5
]}

Pfeffer, Marc A. ^{[3
,4
]}

机构：

[1] Flinders Med Ctr, Cardiol Dept, Flinders Dr, Adelaide, SA 5042, Australia

[2] Flinders Univ S Australia, Adelaide, SA, Australia

[3] Brigham & Womens Hosp, Cardiovasc Div, Boston, MA USA

[4] Harvard Med Sch, Boston, MA USA

[5] Brigham & Womens Hosp, Cardiovasc Div, TIMI Study Grp, Boston, MA USA

[6] Univ Glasgow, British Heart Fdn Cardiovasc Res Ctr, Glasgow, Scotland

[7] Washington Univ, Med Ctr, St. Louis, MO USA

[8] Duke Univ, Med Ctr, Durham, NC USA

[9] Rigshospitalet, Blegdamsvej, Copenhagen, Denmark

[10] Heart Care Fdn, ANMCO Res Ctr, Florence, Italy

[11] Univ Montreal, Montreal Heart Inst, Quebec City, PQ, Canada

[12] Univ Paris Cite, Hop Bichat, AP HP, INSERM U 1148,French Alliance Cardiovasc Trials, Paris, France

[13] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands

来源：

CIRCULATION-HEART FAILURE | 2024年 / 17卷 / 07期

关键词：

chronic disease; heart failure; myocardial infarction; physicians; valsartan;

D O I：

10.1161/CIRCHEARTFAILURE.123.011393

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：4

共 13 条

[1] Safety and Tolerability of Angiotensin Receptor Neprilysin Inhibitor Initiation in High-Risk Acute Myocardial Infarction Relative to Drug Initiation Setting: A Subgroup Analysis of the PARADISE-MI Trial
De Pasquale, Carmine
Claggett, Brian
Jering, Karola
McMurray, John J.
Mann, Douglas L.
Granger, Christopher
Kober, Lars
Lewis, Eldrin F.
Maggioni, Aldo Pietro P.
Rouleau, Jean L.
Solomon, Scott
Steg, Philippe G.
van der Meer, Peter
Braunwald, Eugene
Pfeffer, Marc A.
CIRCULATION, 2023, 148
[2] The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial
Mehran, Roxana
Steg, Philippe Gabriel
Pfeffer, Marc A.
Jering, Karola
Claggett, Brian
Lewis, Eldrin F.
Granger, Christopher
Kober, Lars
Maggioni, Aldo
Mann, Douglas L.
McMurray, John J. V.
Rouleau, Jean-Lucien
Solomon, Scott D.
Ducrocq, Gregory
Berwanger, Otavio
De Pasquale, Carmine G.
Landmesser, Ulf
Petrie, Mark
Leng, David Sim Kheng
van der Meer, Peter
Lefkowitz, Martin
Zhou, Yinong
Braunwald, Eugene
CIRCULATION, 2022, 146 (23) : 1749 - 1757
[3] Atrial fibrillation in patients with high-risk acute myocardial infarction the PARADISE-MI trial
Cikes, M.
Jering, K.
Claggett, B.
Amir, O.
Bonfanti, A. J. Cadena
Chos, M. -C.
Granger, C.
Gullestad, L. -M.
Kao, H. -L.
Morais, J.
Tanguay, J. -F.
Tokmakova, M.
Widimsky, P.
Solomon, S. D.
EUROPEAN HEART JOURNAL, 2022, 43 : 1178 - 1178
[4] Development of Heart Failure in High-Risk Post-Myocardial Infarction Patients: An Analysis of the Paradise-MI Trial
VanDer Meer, Peter
Braunwald, Eugene
Pfeffer, Marc A.
Granger, Christopher
Kober, Lars
Lewis, Eldrin F.
Maggioni, Aldo Pietro P.
Mann, Douglas L.
McMurray, John J.
Rouleau, Jean L.
Solomon, Scott
Steg, Philippe G.
Jering, Karola
Berry, Gerald A.
Fernandez, Alberto
Claggett, Brian
CIRCULATION, 2023, 148
[5] Prognostic importance of NT-proBNP following high-risk myocardial infarction in the PARADISE-MI Trial
Jering, K.
Claggett, B.
Pfeffer, M. A.
Granger, C.
Kober, L.
Lewis, E. F.
Maggioni, A. P.
Mann, D. L.
McMurray, J. J. V.
Prescott, M. F.
Rouleau, J. L.
Solomon, S. D.
Steg, P. G.
Von Lewinski, D.
Braunwald, E.
EUROPEAN HEART JOURNAL, 2022, 43 : 1324 - 1324
[6] Effect of Sacubitril/Valsartan on the Right Ventricle after High-Risk Myocardial Infarction: Insights from the PARADISE-MI Trial
Wang, Xiaowen
Shah, Amil
Claggett, Brian
Taheri, Kimia Karimi
Jering, Karola
Kovacs, Attila
Merkely, Bela
Nagy, Vivien
Cikes, Maja
Rouleau, Jean
Pfeffer, Marc
Solomon, Scott
CIRCULATION, 2024, 150
[7] Efficacy and Safety of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker in Acute Myocardial Infarction Patients: A Meta-Analysis of Randomized Controlled Trials
Ananta, Muammar Emir
Ivan, Ignatius
Wijaya, Alya Darin
Albab, Chabib Fachry
Danny, Siska
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (16) : S23 - S24
[8] Differences in risk profiles and clinical outcomes according to age in patients with high-risk myocardial infarction: insights from the PARADISE-MI trial
Jering, K.
Claggett, B. L.
Solomon, S. D.
Cikes, M.
Granger, C. B.
Kober, L.
Landmesser, U.
Lewis, E. F.
Maggioni, A. P.
Mcmurray, J. J., V
Merkely, B.
Opolski, G.
Rouleau, J. L.
Senni, M.
Pfeffer, M. A.
EUROPEAN HEART JOURNAL, 2024, 45
[9] Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial
Jering, Karola S.
Claggett, Brian L.
Pfeffer, Marc A.
Granger, Christopher B.
Kober, Lars
Lewis, Eldrin F.
Maggioni, Aldo P.
Mann, Douglas L.
McMurray, John J. V.
Prescott, Margaret F.
Rouleau, Jean L.
Solomon, Scott D.
Steg, Phillippe Gabriel
von Lewinski, Dirk
Braunwald, Eugene
CIRCULATION-HEART FAILURE, 2023, 16 (05) : 389 - 399
[10] Prognostic importance of persistent elevations in high-sensitivity troponin T in the early convalescent phase (two weeks) following high-risk myocardial infarction: insights from the PARADISE-MI trial
Jering, K.
Claggett, B. L.
Pfeffer, M. A.
Amir, O.
Barkoudah, E.
Kober, L.
Maggioni, A. M.
Mann, D. L.
Mcmurray, J. J., V
Mehran, R.
Ntsekhe, M.
Solomon, S. D.
Steg, P. G.
Tokmakova, M.
Braunwald, E.
EUROPEAN HEART JOURNAL, 2024, 45

← 1 2 →